Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance

Neurotoxicity Research

Volumn 20, Issue 4, 2011, Pages 387-401

  Feng, Li Rebekah ^a   Maguire Zeiss, Kathleen A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine; Leak channel; Oxidative stress; Paraquat; Parkinson's disease; Pore

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; HEME OXYGENASE 1; PARAQUAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MOUSE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALPHA-SYNUCLEIN; ANALYSIS OF VARIANCE; ANIMALS; CELL LINE, TUMOR; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOXYCYCLINE; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HEME OXYGENASE-1; HERBICIDES; HUMANS; LEVODOPA; MEMBRANE POTENTIALS; MICE; NERVE TISSUE PROTEINS; NEUROBLASTOMA; PARAQUAT; PATCH-CLAMP TECHNIQUES; PERMEABILITY; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION; TUBULIN; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 80053916936     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9255-x     Document Type: Article

References (155)

1. A Abeliovich Y Schmitz I Fariñas D Choi-Lundberg W-H Ho PE Castillo N Shinsky JMG Verdugo M Armanini A Ryan M Hynes H Phillips D Sulzer A Rosenthal 2000 Mice lacking [alpha]-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 239 252 10707987 1:CAS:528: DC%2BD3cXhtVWrt74%3D (Pubitemid 30316525)
2. ZI Alam SE Daniel AJ Lees DC Marsden P Jenner B Halliwell 1997 A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental lewy body disease J Neurochem 69 1326 1329 9282961 1:CAS:528:DyaK2sXls1Chu70%3D (Pubitemid 27364859)
3. ZI Alam A Jenner SE Daniel AJ Lees N Cairns CD Marsden P Jenner B Halliwell 1997 Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra J Neurochem 69 1196 1203 9282943 1:CAS:528:DyaK2sXls1Chtbs%3D (Pubitemid 27364841)
4. BN Ames MK Shigenaga TM Hagen 1993 Oxidants, antioxidants, and the degenerative diseases of aging Proc Natl Acad Sci USA 90 7915 7922 8367443 1:CAS:528:DyaK3sXmtVSksL4%3D (Pubitemid 23260825)
5. PK Auluck G Caraveo S Lindquist 2010 α-Synuclein: membrane interactions and toxicity in Parkinson's disease Annu Rev Cell Dev Biol 26 211 233 20500090 1:CAS:528:DC%2BC3cXhsFCnur7F
6. A Barbeau L Dallaire N Buu J Poirier E Rucinska 1985 Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens Life Sci 37 1529 1538 3876500 1:CAS:528:DyaL2MXlvFWjt7w%3D (Pubitemid 15239540)
7. MF Beal 2003 Mitochondria, oxidative damage, and inflammation in Parkinson's disease Ann N Y Acad Sci 991 120 131 12846981 1:CAS:528: DC%2BD3sXmtVCku78%3D (Pubitemid 36793808)
8. M Bisaglia S Mammi L Bubacco 2007 Kinetic and structural analysis of the early oxidation products of dopamine J Biol Chem 282 15597 15605 17395592 1:CAS:528:DC%2BD2sXltl2gu7Y%3D
9. NA Bishop T Lu BA Yankner 2010 Neural mechanisms of ageing and cognitive decline Nature 464 529 535 20336135 1:CAS:528:DC%2BC3cXjvVGlu7o%3D
10. AT Black JP Gray MP Shakarjian DL Laskin DE Heck JD Laskin 2008 Increased oxidative stress and antioxidant expression in mouse keratinocytes following exposure to paraquat Toxicol Appl Pharmacol 231 384 392 18620719 1:CAS:528:DC%2BD1cXhtVylurnK
11. H Braak E Ghebremedhin U Rüb H Bratzke K Del Tredici 2004 Stages in the development of Parkinson's disease-related pathology Cell Tissue Res 318 121 134 15338272 (Pubitemid 39362633)
12. AI Brooks CA Chadwick HA Gelbard DA Cory-Slechta HJ Federoff 1999 Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss Brain Res 823 1 10 10095006 1:CAS:528:DyaK1MXhvVCntrw%3D (Pubitemid 29225488)
13. J Burre M Sharma T Tsetsenis V Buchman MR Etherton TC Sudhof 2010 {Alpha}-synuclein promotes SNARE-complex assembly in vivo and in vitro Science 329 1663 1667 20798282 1:CAS:528:DC%2BC3cXhtFOqsrvN
14. DE Cabin K Shimazu D Murphy NB Cole W Gottschalk KL McIlwain B Orrison A Chen CE Ellis R Paylor B Lu RL Nussbaum 2002 Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein J Neurosci 22 8797 8807 12388586 1:CAS:528:DC%2BD38XosV2juro%3D (Pubitemid 35379049)
15. MJ Calkins DA Johnson JA Townsend MR Vargas JA Dowell TP Williamson AD Kraft J-M Lee J Li JA Johnson 2009 The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease Antioxid Redox Signal 11 497 508 18717629 1:CAS:528:DC%2BD1MXhtFOrtLg%3D
16. R Cappai S-L Leck DJ Tew NA Williamson DP Smith D Galatis RA Sharples CC Curtain FE Ali RA Cherny JG Culvenor SP Bottomley CL Masters KJ Barnham AF Hill 2005 Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway FASEB J 19 1377 1379 15946991 1:CAS:528:DC%2BD2MXntlaqt7w%3D (Pubitemid 41113755)
17. PM Carvey A Punati MB Newman 2006 Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis Cell Transplant 15 239 250 16719059 (Pubitemid 43726183)
18. WM Caudle RE Colebrooke PC Emson GW Miller 2008 Altered vesicular dopamine storage in Parkinson's disease: a premature demise Trends Neurosci 31 303 308 18471904 1:CAS:528:DC%2BD1cXmvV2isb0%3D
19. B Caughey PT Lansbury 2003 Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu Rev Neurosci 26 267 298 12704221 1:CAS:528: DC%2BD3sXntFSisL0%3D (Pubitemid 37064935)
20. CXQ Chen SY Huang L Zhang Y-J Liu 2005 Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells Neurobiol Dis 19 419 426 16023584 (Pubitemid 40968055)
21. P-C Chen MR Vargas AK Pani RJ Smeyne DA Johnson YW Kan JA Johnson 2009 Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte Proc Natl Acad Sci USA 106 2933 2938 19196989 1:CAS:528:DC%2BD1MXislSkurg%3D
22. HK Choi LA Won PJ Kontur DN Hammond AP Fox BH Wainer PC Hoffmann A Heller 1991 Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion Brain Res 552 67 76 1913182 1:CAS:528:DyaK3MXltVKrsLk%3D
23. H Choi L Won J Roback B Wainer A Heller 1992 Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions Proc Natl Acad Sci USA 89 8943 8947 1357658 1:CAS:528: DyaK38Xmt1Kru7k%3D
24. F Cicchetti J Drouin-Ouellet RE Gross 2009 Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30 475 483 19729209 1:CAS:528:DC%2BD1MXhtV2rtb3E
25. L Clejan AI Cederbaum 1989 Synergistic interactions between nadph-cytochrome P-450 reductase, paraquat, and iron in the generation of active oxygen radicals Biochem Pharmacol 38 1779 1786 2500125 1:CAS:528: DyaL1MXltFSntLw%3D (Pubitemid 19138527)
26. HM Cocheme MP Murphy 2008 Complex I is the major site of mitochondrial superoxide production by paraquat J Biol Chem 283 1786 1798 18039652 1:CAS:528:DC%2BD1cXnsFCisQ%3D%3D
27. KA Conway JD Harper PT Lansbury 1998 Accelerated in vitro fibril formation by a mutant [alpha]-synuclein linked to early-onset Parkinson disease Nat Med 4 1318 1320 9809558 1:CAS:528:DyaK1cXntlakur0%3D (Pubitemid 28512115)
28. KA Conway JC Rochet RM Bieganski PT Lansbury Jr 2001 Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 1346 1349 11701929 1:CAS:528:DC%2BD3MXotlKmurk%3D (Pubitemid 33063102)
29. MR Cookson 2005 The biochemistry of Parkinson's disease Annu Rev Biochem 74 29 52 15952880 1:CAS:528:DC%2BD2MXpsVensrk%3D (Pubitemid 40995500)
30. MR Cookson M van der Brug 2008 Cell systems and the toxic mechanism(s) of alpha-synuclein Exp Neurol 209 5 11 17603039 1:CAS:528:DC%2BD1cXivFegsQ%3D%3D
31. DA Cory-Slechta M Thiruchelvam BK Barlow EK Richfield 2005 Developmental pesticide models of the Parkinson disease phenotype Environ Health Perspect 113 1263 1270 16140639 1:CAS:528:DC%2BD2MXht1agu7nK (Pubitemid 41387671)
32. E Croisier LB Moran DT Dexter RKB Pearce MB Graeber 2005 Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition J Neuroinflammation 2 14 15935098
33. KM Danzer D Haasen AR Karow S Moussaud M Habeck A Giese H Kretzschmar B Hengerer M Kostka 2007 Different species of alpha-synuclein oligomers induce calcium influx and seeding J Neurosci 27 9220 9232 17715357 1:CAS:528: DC%2BD2sXhtVSnsLfM (Pubitemid 47312071)
34. F Darios V Ruiperez I Lopez J Villanueva LM Gutierrez B Davletov 2010 [Alpha]-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis EMBO Rep 11 528 533 20489724 1:CAS:528:DC%2BC3cXmtlamtrg%3D
35. CA Davie 2008 A review of Parkinson's disease Br Med Bull 86 109 127 18398010 1:STN:280:DC%2BD1czlt1Kqsg%3D%3D (Pubitemid 351809630)
36. BJ Day M Patel L Calavetta L-Y Chang JS Stamler 1999 A mechanism of paraquat toxicity involving nitric oxide synthase Proc Natl Acad Sci USA 96 12760 12765 10535996 1:CAS:528:DyaK1MXnt1yqsbk%3D (Pubitemid 29513576)
37. DT Dexter CJ Carter FR Wells F Javoy-Agid Y Agid A Lees P Jenner CD Marsden 1989 Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease J Neurochem 52 381 389 2911023 1:CAS:528:DyaL1MXhtFalsrc%3D (Pubitemid 19037600)
38. DT Dexter AE Holley WD Flitter TF Slater FR Wells SE Daniel AJ Lees P Jenner CD Marsden 1994 Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study Mov Disord 9 92 97 8139611 1:STN:280:DyaK2c7oslOruw%3D%3D (Pubitemid 24022621)
39. DA Di Monte M Lavasani AB Manning-Bog 2002 Environmental factors in Parkinson's disease Neurotoxicology 23 487 502 12428721 1:CAS:528: DC%2BD38XnvVGrtL0%3D (Pubitemid 36527669)
40. E Dicker AI Cederbaum 1991 NADH-dependent generation of reactive oxygen species by microsomes in the presence of iron and redox cycling agents Biochem Pharmacol 42 529 535 1650215 1:CAS:528:DyaK3MXlt12mt7g%3D
41. TT Ding S-J Lee J-C Rochet PT Lansbury Jr 2002 Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes Biochemistry 41 10209 10217 12162735 1:CAS:528:DC%2BD38XlsVShurc%3D (Pubitemid 34856445)
42. RJ Dinis-Oliveira F Remião H Carmo JA Duarte AS Navarro ML Bastos F Carvalho 2006 Paraquat exposure as an etiological factor of Parkinson's disease Neurotoxicology 27 1110 1122 16815551 1:CAS:528:DC%2BD28Xht12rsLnF (Pubitemid 44838957)
43. Y Dong ML Heien MM Maxson AG Ewing 2008 Amperometric measurements of catecholamine release from single vesicles in MN9D cells J Neurochem 107 1589 1595 19094057 1:CAS:528:DC%2BD1MXis1Skuw%3D%3D
44. JE Duda VMY Lee JQ Trojanowski 2000 Neuropathology of synuclein aggregates J Neurosci Res 61 121 127 10878583 1:CAS:528:DC%2BD3cXkslOgsbc%3D
45. G Eisenhofer IJ Kopin DS Goldstein 2004 Catecholamine metabolism: a contemporary view with implications for physiology and medicine Pharmacol Rev 56 331 349 15317907 1:CAS:528:DC%2BD2cXotVKjtbs%3D (Pubitemid 39096594)
46. OMA El-Agnaf SA Salem KE Paleologou LJ Cooper NJ Fullwood MJ Gibson MD Curran JA Court DMA Mann S-I Ikeda MR Cookson J Hardy D Allsop 2003 Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma FASEB J 17 1945 1947 14519670 1:CAS:528:DC%2BD3sXot1Kit7Y%3D
47. A Elbaz C Dufouil A Alpérovitch 2007 Interaction between genes and environment in neurodegenerative diseases C R Biol 330 318 328 17502288 1:CAS:528:DC%2BD2sXlt1akur0%3D (Pubitemid 46712172)
48. L Engel H Checkoway M Keifer N Seixas W Longstreth K Scott K Hudnell W Anger R Camicioli 2001 Parkinsonism and occupational exposure to pesticides Occup Environ Med 58 582 589 11511745 1:CAS:528:DC%2BD3MXmvV2rt78%3D (Pubitemid 32772511)
49. Q Fei AL McCormack DA Di Monte DW Ethell 2008 Paraquat neurotoxicity is mediated by a Bak-dependent mechanism J Biol Chem 283 3357 3364 18056701 1:CAS:528:DC%2BD1cXhtlyju70%3D
50. LR Feng HJ Federoff S Vicini KA Maguire-Zeiss 2010 α-Synuclein mediates alterations in membrane conductance: a potential role for α-synuclein oligomers in cell vulnerability Eur J Neurosci 32 10 17
51. PO Fernagut CB Hutson SM Fleming NA Tetreaut J Salcedo E Masliah MF Chesselet 2007 Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression Synapse 61 991 1001 17879265 1:CAS:528:DC%2BD2sXht1Knt7vN (Pubitemid 350271779)
52. AL Fink 2006 The aggregation and fibrillation of α-synuclein Acc Chem Res 39 628 634 16981679 1:CAS:528:DC%2BD28XptFaitrc%3D
53. DL Fortin VM Nemani SM Voglmaier MD Anthony TA Ryan RH Edwards 2005 Neural activity controls the synaptic accumulation of {alpha}-synuclein J Neurosci 25 10913 10921 16306404 1:CAS:528:DC%2BD2MXht1yks7%2FP (Pubitemid 41692621)
54. K Furukawa M Matsuzaki-Kobayashi T Hasegawa A Kikuchi N Sugeno Y Itoyama Y Wang PJ Yao I Bushlin A Takeda 2006 Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells J Neurochem 97 1071 1077 16606366 1:CAS:528:DC%2BD28XlsVOnt78%3D
55. MS Goldberg PT Lansbury Jr 2000 Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2 E115 E119 10878819 1:CAS:528:DC%2BD3cXkvFCqsbw%3D
56. J Gorell C Johnson B Rybicki E Peterson R Richardson 1998 The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living Neurology 50 1346 1350 9595985 1:STN:280:DyaK1c3lsFChtg%3D%3D (Pubitemid 28240350)
57. DG Graham SM Tiffany WR Bell WF Gutknecht 1978 Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro Mol Pharmacol 14 644 653 567274 1:CAS:528:DyaE1MXit10%3D (Pubitemid 8402470)
58. JT Greenamyre TG Hastings 2004 Biomedicine: Parkinson's-divergent causes, convergent mechanisms Science 304 1120 1122 15155938 1:CAS:528: DC%2BD2cXkt1Kjt78%3D (Pubitemid 38661838)
59. JN Guzman J Sanchez-Padilla D Wokosin J Kondapalli E Ilijic PT Schumacker DJ Surmeier 2010 Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 Nature 468 696 700 21068725 1:CAS:528:DC%2BC3cXhtl2rtb7F
60. TH Hamza CP Zabetian A Tenesa A Laederach J Montimurro D Yearout DM Kay KF Doheny J Paschall E Pugh VI Kusel R Collura J Roberts A Griffith A Samii WK Scott J Nutt SA Factor H Payami 2010 Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease Nat Genet 42 781 785 20711177 1:CAS:528:DC%2BC3cXhtVaisL7J
61. CH Hawkes KD Tredici H Braak 2009 Parkinson's disease Ann N Y Acad Sci 1170 615 622 19686202
62. KB Heller B Poser CWM Haest B Deuticke 1984 Oxidative stress of human erythrocytes by iodate and periodate Reversible formation of aqueous membrane pores due to SH-group oxidation Biochim Biophys Acta Biomembranes 777 107 116 1:CAS:528:DyaL2cXlvVyqs7c%3D (Pubitemid 15218833)
63. YO Herishanu M Medvedovski JR Goldsmith E Kordysh 2001 A case-control study of Parkinson's disease in urban population of southern Israel Can J Neurol Sci 28 144 147 11383940 1:STN:280:DC%2BD3MzhtVygsg%3D%3D (Pubitemid 32521804)
64. FE Herrera A Chesi KE Paleologou A Schmid A Munoz M Vendruscolo S Gustincich HA Lashuel P Carloni 2008 Inhibition of α-synuclein fibrillization by dopamine is mediated by interactions with five C-terminal residues and with E83 in the NAC region PLoS ONE 3 e3394 18852892
65. JV Hindle 2010 Ageing, neurodegeneration and Parkinson's disease Age Ageing 39 156 161 20051606
66. JP Hubble T Cao RES Hassanein JS Neuberger WC Roller 1993 Risk factors for Parkinson's disease Neurology 43 1693 1697 8414014 1:STN:280: DyaK2c%2FitVarug%3D%3D (Pubitemid 23307937)
67. S-Y Hung H-C Liou K-H Kang R-M Wu C-C Wen W-M Fu 2008 Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4- phenylpyridinium-induced neurotoxicity Mol Pharmacol 74 1564 1575 18799798 1:CAS:528:DC%2BD1cXhsVGls73I
68. P Jenner 2003 Oxidative stress in Parkinson's disease Ann Neurol 53 S26 S38 12666096 1:CAS:528:DC%2BD3sXjtFGitLs%3D (Pubitemid 36368560)
69. MJ Kang SJ Gil HC Koh 2009 Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice Toxicol Lett 188 148 152 19446248 1:CAS:528:DC%2BD1MXmtVKhsrc%3D
70. MJ Kang SJ Gil JE Lee HC Koh 2010 Selective vulnerability of the striatal subregions of C57BL/6 mice to paraquat Toxicol Lett 195 127 134 20307631 1:CAS:528:DC%2BC3cXlsFans7s%3D
71. PA Kempster B Hurwitz AJ Lees 2007 A new look at James Parkinson's Essay on the Shaking Palsy Neurology 69 482 485 17664408 (Pubitemid 47454480)
72. ST Kim JH Choi JW Chang SW Kim O Hwang 2005 Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system J Neurochem 95 89 98 16181415 1:CAS:528:DC%2BD2MXhtVygs7fM (Pubitemid 41384428)
73. C Klein MG Schlossmacher 2007 Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder Neurology 69 2093 2104 17761553 (Pubitemid 350175712)
74. M Kostka T Hogen KM Danzer J Levin M Habeck A Wirth R Wagner CG Glabe S Finger U Heinzelmann P Garidel W Duan CA Ross H Kretzschmar A Giese 2008 Single particle characterization of iron-induced pore-forming {alpha}-synuclein oligomers J Biol Chem 283 10992 11003 18258594 1:CAS:528:DC%2BD1cXksFagurg%3D
75. R Krüger W Kuhn T Müller D Woitalla M Graeber S SKösel H Przuntek JT Epplen L Schols O Riess 1998 Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat Genet 18 106 108 9462735
76. BCL Lai SA Marion K Teschke JKC Tsui 2002 Occupational and environmental risk factors for Parkinson's disease Parkinsonism Relat Disord 8 297 309 15177059 1:STN:280:DC%2BD2c3nvFenug%3D%3D (Pubitemid 34520454)
77. HA Lashuel D Hartley BM Petre T Walz PT Lansbury Jr 2002 Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 418 291 12124613 1:CAS:528:DC%2BD38XltlGmsrc%3D (Pubitemid 34790672)
78. MJ LaVoie TG Hastings 1999 Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine J Neurosci 19 1484 1491 9952424 1:CAS:528:DyaK1MXhtFOgtbY%3D (Pubitemid 29088929)
79. MJ LaVoie BL Ostaszewski A Weihofen MG Schlossmacher DJ Selkoe 2005 Dopamine covalently modifies and functionally inactivates parkin Nat Med 11 1214 1221 16227987 1:CAS:528:DC%2BD2MXhtFOhsLvP (Pubitemid 43093669)
80. AJ Lees J Hardy T Revesz 2009 Parkinson's disease Lancet 373 2055 2066 19524782 1:CAS:528:DC%2BD1MXnt1ans7w%3D
81. H-T Li D-H Lin X-Y Luo F Zhang L-N Ji H-N Du G-Q Song J Hu J-W Zhou H-Y Hu 2005 Inhibition of α-synuclein fibrillization by dopamine analogs via reaction with the amino groups of α-synuclein FEBS J 272 3661 3672 16008565 1:CAS:528:DC%2BD2MXntVaqsb4%3D (Pubitemid 41021178)
82. C-S Lim J-C Lee SD Kim D-J Chang B-K Kaang 2002 Hydrogen peroxide-induced cell death in cultured Aplysia sensory neurons Brain Res 941 137 145 12031556 1:CAS:528:DC%2BD38XjvVSgsLw%3D (Pubitemid 34603292)
83. H Liou M Tsai C Chen J Jeng Y Chang S Chen R Chen 1997 Environmental risk factors and Parkinson's disease: a case-control study in Taiwan Neurology 48 1583 1588 9191770 1:STN:280:DyaK2szjsFWjtg%3D%3D
84. B Liu H-M Gao J-S Hong 2003 Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation Environ Health Perspect 111 1065 1073 12826478 1:CAS:528:DC%2BD3sXlvF2ksro%3D (Pubitemid 36826886)
85. J Lotharius P Brundin 2002 Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein Nat Rev Neurosci 3 932 942 12461550 1:CAS:528:DC%2BD38XptFKntbk%3D
86. Y Luo LA Henricksen RE Giuliano L Prifti LM Callahan HJ Federoff 2007 VIP is a transcriptional target of Nurr1 in dopaminergic cells Exp Neurol 203 221 232 16999955 1:CAS:528:DC%2BD28Xht1Krt73O (Pubitemid 44821180)
87. R Macianskiene P Matejovic K Sipido W Flameng K Mubagwa 2001 Modulation of the extracellular divalent cation-inhibited non-selective conductance in cardiac cells by metabolic inhibition and by oxidants J Mol Cell Cardiol 33 1371 1385 11437543 1:CAS:528:DC%2BD3MXkvVOktrY%3D (Pubitemid 32613429)
88. KA Maguire-Zeiss HJ Federoff 2003 Convergent pathobiologic model of Parkinson's disease Ann N Y Acad Sci 991 152 166 12846984 1:CAS:528: DC%2BD3sXmtVCku7o%3D (Pubitemid 36793811)
89. KA Maguire-Zeiss DW Short HJ Federoff 2005 Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Mol Brain Res 134 18 23 15790526 1:CAS:528:DC%2BD2MXisFGmurY%3D (Pubitemid 40409494)
90. KA Maguire-Zeiss CI Wang E Yehling MA Sullivan DW Short X Su G Gouzer LA Henricksen CA Wuertzer HJ Federoff 2006 Identification of human [alpha]-synuclein specific single chain antibodies Biochem Biophys Res Commun 349 1198 1205 16973126 1:CAS:528:DC%2BD28XpvFGjs74%3D (Pubitemid 44416388)
91. S Mandel E Grunblatt P Riederer N Amariglio J Jacob-Hirsch G Rechavi MBH Youdim 2005 Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70 Ann N Y Acad Sci 1053 356 375 16179542 1:CAS:528:DC%2BD28XotlKqsQ%3D%3D (Pubitemid 43031116)
92. AB Manning-Bog AL McCormack J Li VN Uversky AL Fink DA Di Monte 2002 The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice J Biol Chem 277 1641 1644 11707429 1:CAS:528:DC%2BD38XosFaquw%3D%3D (Pubitemid 34968732)
93. AB Manning-Bog AL McCormack MG Purisai LM Bolin DA Di Monte 2003 Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration J Neurosci 23 3095 3099 12716914 1:CAS:528: DC%2BD3sXjsFSksL8%3D (Pubitemid 36531948)
94. E Mariani MC Polidori A Cherubini P Mecocci 2005 Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview J Chromatogr B 827 65 75 1:CAS:528:DC%2BD2MXhtFOmsbnI (Pubitemid 41551598)
95. L Maroteaux JT Campanelli RH Scheller 1988 Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal J Neurosci 8 2804 2815 3411354 1:CAS:528:DyaL1MXhsVyqsbY%3D
96. MP Mattson WA Pedersen W Duan C Culmsee S Camandola 1999 Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases Ann N Y Acad Sci 893 154 175 10672236 1:CAS:528:DC%2BD3cXms1Gntw%3D%3D (Pubitemid 30038074)
97. JR Mazzulli AJ Mishizen BI Giasson DR Lynch SA Thomas A Nakashima T Nagatsu A Ota H Ischiropoulos 2006 Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates J Neurosci 26 10068 10078 17005870 1:CAS:528:DC%2BD28XhtVOmtLfM (Pubitemid 44477168)
98. JR Mazzulli M Armakola M Dumoulin I Parastatidis H Ischiropoulos 2007 Cellular oligomerization of α-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence J Biol Chem 282 31621 31630 17785456 1:CAS:528:DC%2BD2sXhtFykurfP (Pubitemid 350044848)
99. AL McCormack DA Di Monte 2003 Effects of l-dopa and other amino acids against paraquat-induced nigrostriatal degeneration J Neurochem 85 82 86 12641729 1:CAS:528:DC%2BD3sXislOltb0%3D (Pubitemid 36389697)
100. AL McCormack M Thiruchelvam AB Manning-Bog C Thiffault JW Langston DA Cory-Slechta DA Di Monte 2002 Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat Neurobiol Dis 10 119 127 12127150 1:CAS:528: DC%2BD38XltFyrtbs%3D (Pubitemid 34775465)
101. AL McCormack JG Atienza LC Johnston JK Andersen S Vu DA Di Monte 2005 Role of oxidative stress in paraquat-induced dopaminergic cell degeneration J Neurochem 93 1030 1037 15857406 1:CAS:528:DC%2BD2MXksFKnsrw%3D (Pubitemid 40695762)
102. AL McCormack JG Atienza JW Langston DA Di Monte 2006 Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration Neuroscience 141 929 937 16677770 1:CAS:528:DC%2BD28XntFShtrg%3D (Pubitemid 44066639)
103. L Migliore F Coppedè 2009 Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases Mutat Res 667 82 97 19026668 1:CAS:528:DC%2BD1MXnsl2iu7o%3D
104. L Migliore F Coppedè 2009 Environmental-induced oxidative stress in neurodegenerative disorders and aging Mutat Res 674 73 84 18952194 1:CAS:528:DC%2BD1MXjtF2htb4%3D
105. R Miller M James-Kracke G Sun A Sun 2009 Oxidative and inflammatory pathways in Parkinson's disease Neurochem Res 34 55 65 18363100 1:CAS:528:DC%2BD1MXktVejtw%3D%3D
106. EV Mosharov KE Larsen E Kanter KA Phillips K Wilson Y Schmitz DE Krantz K Kobayashi RH Edwards D Sulzer 2009 Interplay between cytosolic dopamine, calcium, and [alpha]-synuclein causes selective death of substantia nigra neurons Neuron 62 218 229 19409267 1:CAS:528:DC%2BD1MXlvFSrtrs%3D
107. CEH Moussa F Mahmoodian Y Tomita A Sidhu 2008 Dopamine differentially induces aggregation of A53T mutant and wild type alpha-synuclein: insights into the protein chemistry of Parkinson's disease Biochem Biophys Res Commun 365 833 839 18039462 1:CAS:528:DC%2BD2sXhsVCks7bI (Pubitemid 350234866)
108. DD Murphy SM Rueter JQ Trojanowski VMY Lee 2000 Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons J Neurosci 20 3214 3220 10777786 1:CAS:528:DC%2BD3cXivFKhtL4%3D (Pubitemid 30263139)
109. VM Nemani W Lu V Berge K Nakamura B Onoa MK Lee FA Chaudhry RA Nicoll RH Edwards 2010 Increased expression of [alpha]-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis Neuron 65 66 79 20152114 1:CAS:528:DC%2BC3cXlt1KmsLw%3D
110. EH Norris BI Giasson R Hodara S Xu JQ Trojanowski H Ischiropoulos VMY Lee 2005 Reversible inhibition of α-synuclein fibrillization by dopaminochrome-mediated conformational alterations J Biol Chem 280 21212 21219 15817478 1:CAS:528:DC%2BD2MXks1els7s%3D (Pubitemid 40805683)
111. EH Norris K Uryu S Leight BI Giasson JQ Trojanowski VMY Lee 2007 Pesticide exposure exacerbates [alpha]-synucleinopathy in an A53T transgenic mouse model Am J Pathol 170 658 666 17255333 1:CAS:528:DC%2BD2sXitlOlt7s%3D (Pubitemid 47339402)
112. TF Outeiro J Klucken K Bercury J Tetzlaff P Putcha LMA Oliveira A Quintas PJ McLean BT Hyman 2009 Dopamine-induced conformational changes in alpha-synuclein PLoS ONE 4 e6906 19730729
113. KE Paleologou A Oueslati G Shakked CC Rospigliosi H-Y Kim GR Lamberto CO Fernandez A Schmid F Chegini WP Gai D Chiappe M Moniatte BL Schneider P Aebischer D Eliezer M Zweckstetter E Masliah HA Lashuel 2010 Phosphorylation at S87 is enhanced in synucleinopathies, inhibits {alpha}-synuclein oligomerization, and influences synuclein-membrane interactions J Neurosci 30 3184 3198 20203178 1:CAS:528:DC%2BC3cXjtFahtLo%3D
114. R Pamplona 2008 Membrane phospholipids, lipoxidative damage and molecular integrity: a causal role in aging and longevity Biochim Biophys Acta Bioenergetics 1777 1249 1262 1:CAS:528:DC%2BD1cXhtFylsrvP
115. A Papadimitriou V Veletza GM Hadjigeorgiou A Patrikiou M Hirano I Anastasopoulos 1999 Mutated {alpha}-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance? Neurology 52 651 654 10025809 1:STN:280:DyaK1M7kvVKktA%3D%3D (Pubitemid 29075625)
116. J Peng XO Mao FF Stevenson M Hsu JK Andersen 2004 The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway J Biol Chem 279 32626 32632 15155744 1:CAS:528:DC%2BD2cXmtVCht7k%3D (Pubitemid 39014720)
117. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Di Iorio LI Golbe RL Nussbaum 1997 Mutation in the {alpha}-synuclein gene identified in families with Parkinson's disease Science 276 2045 2047 9197268 1:CAS:528:DyaK2sXkt1altr4%3D (Pubitemid 27443610)
118. DL Pountney R Lowe M Quilty JC Vickers NH Voelcker WP Gai 2004 Annular α-synuclein species from purified multiple system atrophy inclusions J Neurochem 90 502 512 15228606 1:CAS:528:DC%2BD2cXmtVyrtL4%3D (Pubitemid 38938235)
119. K Prasad B Winnik MJ Thiruchelvam B Buckley O Mirochnitchenko EK Richfield 2007 Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain Environ Health Perspect 115 1448 1453 17938734 1:CAS:528: DC%2BD2sXht1ertrrL (Pubitemid 47628332)
120. A Rajput R Uitti W Stern W Laverty K O'Donnell D O'Donnell W Yuen A Dua 1987 Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease Can J Neurol Sci 14 414 418 3676917 1:STN:280:DyaL1c%2Flt1akuw%3D%3D (Pubitemid 17147624)
121. W Satake, et al. 2009 Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease Nat Genet 41 1303 1307 19915576 1:CAS:528:DC%2BD1MXhsVWlsb7O
122. HM Schipper W Song H Zukor JR Hascalovici D Zeligman 2009 Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement J Neurochem 110 469 485 19457088 1:CAS:528:DC%2BD1MXovV2mt7s%3D
123. G Schmuck E Röhrdanz Q Tran-Thi R Kahl G Schlüter 2002 Oxidative stress in rat cortical neurons and astrocytes induced by paraquat in vitro Neurotox Res 4 1 13 12826488 1:CAS:528:DC%2BD38Xmsl2jtbo%3D (Pubitemid 34285040)
124. MD Shtilerman TT Ding PT Lansbury 2002 Molecular crowding accelerates fibrillization of α-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry 41 3855 3860 11900526 1:CAS:528:DC%2BD38XhsV2hsL8%3D (Pubitemid 34251023)
125. J Sian DT Dexter AJ Lees S Daniel Y Agid F Javoy-Agid P Jenner CD Marsden 1994 Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Ann Neurol 36 348 355 8080242 1:STN:280:DyaK2czmtFCltg%3D%3D (Pubitemid 24280055)
126. J Simon-Sanchez, et al. 2009 Genome-wide association study reveals genetic risk underlying Parkinson's disease Nat Genet 41 1308 1312 19915575 1:CAS:528:DC%2BD1MXhsVWlsbrP
127. AB Singleton, et al. 2003 Alpha-synuclein locus triplication causes Parkinson's disease Science 302 841 14593171 1:CAS:528:DC%2BD3sXoslehsbc%3D (Pubitemid 37339619)
128. LL Smith 1985 Paraquat toxicity Philos Trans R Soc Lond B Biol Sci 311 647 657 2869523 1:CAS:528:DyaL28XitVWlsr0%3D
129. CAD Smith CR Wolf AC Gough NK Spurr PN Leigh BA Summers AE Harding DM Maranganore SG Sturman AC Williams AHV Schapira 1992 Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease Lancet 339 1375 1377 1350805 1:STN:280:DyaK383osVOktA%3D%3D
130. W Song A Patel D Han HK Paudel HM Schipper 2008 P2-136: heme oxygenase-1 promotes proteosomal degradation of tau and alpha-synuclein in human neuroblastoma cells Alzheimer's Dement 4 T410
131. W Song A Patel HY Qureshi D Han HM Schipper HK Paudel 2009 The Parkinson disease-associated A30P mutation stabilizes α-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells J Neurochem 110 719 733 19457084 1:CAS:528: DC%2BD1MXovV2mtbk%3D
132. MG Spillantini ML Schmidt VMY Lee JQ Trojanowski R Jakes M Goedert 1997 [Alpha]-synuclein in Lewy bodies Nature 388 839 840 9278044 1:CAS:528: DyaK2sXlslWru7o%3D
133. JV Steidl T Gomez-Isla A Mariash KH Ashe LM Boland 2003 Altered short-term hippocampal synaptic plasticity in mutant [alpha]-synuclein transgenic mice Neuroreport 14 219 223 12598733 (Pubitemid 36308414)
134. CA Strathdee MR McLeod JR Hall 1999 Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector Gene 229 21 29 10095100 1:CAS:528:DyaK1MXit1Knu78%3D (Pubitemid 29148303)
135. X Su KA Maguire-Zeiss R Giuliano L Prifti K Venkatesh HJ Federoff 2008 Synuclein activates microglia in a model of Parkinson's disease Neurobiol Aging 29 1690 1701 17537546 1:CAS:528:DC%2BD1cXhtFCksLzE
136. D Sulzer 2007 Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease Trends Neurosci 30 244 250 17418429 1:CAS:528: DC%2BD2sXkslent7g%3D (Pubitemid 46667168)
137. DJ Surmeier JN Guzman J Sanchez-Padilla 2010 Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease Cell Calcium 47 175 182 20053445 1:CAS:528:DC%2BC3cXjtVSms7s%3D
138. DJ Surmeier JN Guzman J Sanchez-Padilla JA Goldberg B Anders MA Cenci 2010 What causes the death of dopaminergic neurons in Parkinson's disease? Prog Brain Res 183 59 77 20696315 1:CAS:528:DC%2BC3cXhtlGjs77O
139. CM Tanner 2010 Advances in environmental epidemiology Mov Disord 25 S58 S62 20187243
140. M Thiruchelvam BJ Brockel EK Richfield RB Baggs DA Cory-Slechta 2000 Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res 873 225 234 10930548 1:CAS:528:DC%2BD3cXltlekurY%3D (Pubitemid 30619046)
141. MJ Thiruchelvam JM Powers DA Cory-Slechta EK Richfield 2004 Risk factors for dopaminergic neuron loss in human α-synuclein transgenic mice Eur J Neurosci 19 845 854 15009131 1:STN:280:DC%2BD2c7hvFensA%3D%3D (Pubitemid 38297021)
142. IF Tsigelny P Bar-On Y Sharikov L Crews M Hashimoto MA Miller SH Keller O Platoshyn JXJ Yuan E Masliah 2007 Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein FEBS J 274 1862 1877 17381514 1:CAS:528:DC%2BD2sXksFSlsrg%3D (Pubitemid 46426920)
143. IF Tsigelny Y Sharikov MA Miller E Masliah 2008 Mechanism of alpha-synuclein oligomerization and membrane interaction: theoretical approach to unstructured proteins studies Nanomedicine 4 350 357 18640077 1:CAS:528:DC%2BC3cXmtVCksg%3D%3D
144. VN Uversky 2007 Neuropathology, biochemistry, and biophysics of α-synuclein aggregation J Neurochem 103 17 37 17623039 1:CAS:528:DC%2BD2sXhtF2qu7nM (Pubitemid 47407730)
145. VN Uversky J Li AL Fink 2001 Evidence for a partially folded intermediate in alpha-synuclein fibril formation J Biol Chem 276 10737 10744 11152691 1:CAS:528:DC%2BD3MXjvFCqtLs%3D (Pubitemid 38089246)
146. VN Uversky J Li AL Fink 2001 Pesticides directly accelerate the rate of [alpha]-synuclein fibril formation: a possible factor in Parkinson's disease FEBS Lett 500 105 108 11445065 1:CAS:528:DC%2BD3MXkvVelsrg%3D (Pubitemid 32607541)
147. VN Uversky J Li K Bower AL Fink 2002 Synergistic effects of pesticides and metals on the fibrillation of [alpha]-synuclein: implications for Parkinson's disease Neurotoxicology 23 527 536 12428725 1:CAS:528: DC%2BD38XnvVGrtLk%3D (Pubitemid 36527673)
148. VNM Uversky E Cooper KS Bower J Li AL Fink 2002 Accelerated [alpha]-synuclein fibrillation in crowded milieu FEBS Lett 515 99 103 11943202 1:CAS:528:DC%2BD38Xis1eisr0%3D (Pubitemid 34273905)
149. MJ Volles SJ Lee JC Rochet MD Shtilerman TT Ding JC Kessler PT Lansbury Jr 2001 Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease Biochemistry 40 7812 7819 11425308 1:CAS:528:DC%2BD3MXktFOntb0%3D (Pubitemid 32622972)
150. P Weingarten QY Zhou 2001 Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors J Neurochem 77 776 785 11331406 1:CAS:528:DC%2BD3MXjs1WlsLk%3D (Pubitemid 32466774)
151. J Xu S-Y Kao FJS Lee W Song L-W Jin BA Yankner 2002 Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease Nat Med 8 600 606 12042811 1:CAS:528:DC%2BD38XktVyit7w%3D (Pubitemid 34633438)
152. K Yumino I Kawakami M Tamura T Hayashi M Nakamura 2002 Paraquat- and diquat-induced oxygen radical generation and lipid peroxidation in rat brain microsomes J Biochem 131 565 570 11926994 1:CAS:528:DC%2BD38Xkt1Sltrc%3D (Pubitemid 34456612)
153. JJ Zarranz J Alegre JC Gómez-Esteban E Lezcano R Ros I Ampuero L Vidal J Hoenicka O Rodriguez B Atarés V Llorens EG Tortosa T del Ser DG Muñoz JG de Yebenes 2004 The new mutation, E46K, of alpha-synuclein causes parkinson and Lewy body dementia Ann Neurol 55 164 173 14755719 1:CAS:528:DC%2BD2cXhs1Sgtb0%3D (Pubitemid 38166992)
154. ZD Zhou BP Yap AYT Gung SM Leong ST Ang TM Lim 2006 Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein Exp Cell Res 312 156 170 16297908 1:CAS:528:DC%2BD2MXht12rsrnP (Pubitemid 41721178)
155. W Zhou A Gallagher D-P Hong C Long AL Fink VN Uversky 2009 At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to [alpha]-synuclein and prevents its fibrillation J Mol Biol 388 597 610 19328209 1:CAS:528:DC%2BD1MXltVCrsLY%3D